5-(5-Bromo-1-ethyl-2-oxoindolin-3-ylidene)-3-ethyl-2-thioxothiazolidin-4-one

Catalog No. :
ACXKJQ991
CAS No. :
617698-23-4
Molecular Formula :
C15H13BrN2O2S2
Molecular Weight :
397.32

IUPAC Name:(Z)-5-(5-bromo-1-ethyl-2-oxoindolin-3-ylidene)-3-ethyl-2-thioxothiazolidin-4-one

5-(5-Bromo-1-ethyl-2-oxoindolin-3-ylidene)-3-ethyl-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(5-Bromo-1-ethyl-2-oxoindolin-3-ylidene)-3-ethyl-2-thioxothiazolidin-4-one
IUPAC Name(Z)-5-(5-bromo-1-ethyl-2-oxoindolin-3-ylidene)-3-ethyl-2-thioxothiazolidin-4-one
MDL No.MFCD03534875
Molecular FormulaC15H13BrN2O2S2
Molecular Weight397.32
SMILESO=C1N(CC)C2=C(C=C(Br)C=C2)/C1=C(SC(N3CC)=S)\C3=O
InChI KeyUPWIIQHKNRDZRJ-QXMHVHEDSA-N
SynonymSALOR-INT L419591-1EA;(3Z)-5-BROMO-1-ETHYL-3-(3-ETHYL-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE)-1,3-DIHYDRO-2H-INDOL-2-ONE;2H-Indol-2-one, 5-bromo-1-ethyl-3-(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)-1,3-dihydro-
CAS No.617698-23-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXKJQ991 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXKJQ991 route product structure diagram
    ACXKJQ991617698-23-4
Inquiry

2. ACXKJQ991 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXKJQ991 route product structure diagram
    ACXKJQ991617698-23-4
Inquiry

Comments (0)